Canine Adenosine receptor 2a (A2aR) Control/blocking peptide #1

General information
 

Name:
Canine Adenosine receptor 2a (A2aR) Control/blocking peptide #1
Size:
100 ug
Catalog no:
A2aR21-P
Price:
160 EUR
 

Additional extra details
 

  • Stock availability

    Available

    Category

    Antibody Blocking Peptide

    Antibody type

    N/A

  • Antibody host

    N/A

    Antibody conjugate

    N/A

    Technical datasheet

    Contact Gentaur to request the datasheet or ask our specialists for more information.

  • Notes

    The Canine Adenosine receptor 2a (A2aR) Control/blocking peptide #1 is manufactured for Research Use Only or for diagnostics purposes.

    Tissue

    control

    Test

    You can block the antibody by the specific target amino acid sequence of peptide.

  • Properties

    blocking peptide

    Description

    Isotype or positive controls by peptides, antibodies and deactivated samples.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.